Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder

Key facts

Sponsor

Anders Fink-Jensen, MD, DMSci

Intervention

semaglutide(drug)

Enrollment

100 target

Eligibility

18-70 years · All sexes

Timeline

2026 – 2028

Study locations (1)

• Psychiatric Center Copenhagen, Frederiksberg Hospital, Frederiksberg, Denmark

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Primary orthostatic tremor

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT07340554
  Neuroimaging of Adolescent Cannabis Use Treatment
  Indiana University
• ACTIVE NOT RECRUITINGNCT07582445
  Perioperative Prospective Follow Up Of Cannabis Consumers and Discrepancy Use
  Hadassah Medical Organization
• ENROLLING BY INVITATIONNANCT07513337
  Effects of Cannabis Species Labeling and Marketing on Perceptual, Subjective and Objective Use Outcomes (Aim 2 Study)
  Johns Hopkins Bloomberg School of Public Health
• RECRUITINGNANCT07056894
  Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis
  Nova Scotia Health Authority
• RECRUITINGNANCT07196462
  Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia
  Vanderbilt University Medical Center
• RECRUITINGPHASE3NCT05052541
  Safety and Efficacy of Oral Cannabis in Chronic Spine Pain
  University of Colorado, Denver
• RECRUITINGPHASE1NCT07176208
  Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol (Δ9-THC) With and Without Alcohol on Perception and Driving Performance in Healthy Adults
  Food and Drug Administration (FDA)
• RECRUITINGPHASE3NCT07246187
  Comparing Haloperidol to Olanzapine in the Treatment of Suspected Cannabinoid Hyperemesis in the Emergency Department
  Mercy Bon Secours Saint Vincent Medical Center

See all trials for Primary orthostatic tremor →